NCT05893082View on ClinicalTrials.gov

Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 12, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Aortic Stenosis
Interventions
DEVICE

F2 Filter and Delivery System

Placement of F2 device in aorta to cover the great cerebral vessels.

Trial Locations (1)

2065

North Shore Private, Sydney

Sponsors
All Listed Sponsors
lead

EnCompass Technologies, Inc.

INDUSTRY

NCT05893082 - Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR | Biotech Hunter | Biotech Hunter